Table 1 Comparison of the clinicopathological parameters of the patients according to DTC status in bone marrow after primary surgery
Variable | No. of patients n = 154 | Post-operatively DTC status | P-values | |
|---|---|---|---|---|
Positive n = 23 | Negative n = 131 | |||
Age | 0.013 | |||
<=55 years | 78 | 6 (8) | 72 (92) | |
>55 years | 76 | 17 (22) | 59 (78) | |
Lymph node status | 0.223 | |||
pN0 | 110 | 14 (13) | 96 (87) | |
pN1-2 | 44 | 9 (20) | 35 (80) | |
Tumor size | 0.469 | |||
pT1 | 105 | 14 (13) | 91 (87) | |
pT2-4 | 49 | 9 (18) | 40 (82) | |
Tumor grade | 0.803 | |||
1 | 55 | 8 (14) | 47 (86) | |
2 | 61 | 10 (16) | 51 (84) | |
3 | 35 | 4 (11) | 31 (89) | |
Unknown | 3 | |||
Estrogen receptor status | 0.365 | |||
ER positive | 127 | 17 (13) | 110 (87) | |
ER negative | 25 | 5 (20) | 20 (80) | |
Unknown | 2 | |||
Progesterone receptor status | 0.105 | |||
PgR positive | 76 | 15 (20) | 61 (80) | |
PgR negative | 75 | 7 (9) | 68 (91) | |
Unknown | 3 | |||
Histological type | 0.182 | |||
Ductal | 121 | 15 (12) | 106 (88) | |
Lobular | 15 | 3 (20) | 12 (80) | |
Mixed ductal/lobular | 5 | 1 (20) | 4 (80) | |
Other | 13 | 4 (31) | 9 (69) | |
Chemotherapy | 0.798 | |||
Therapy | 41 | 5 (12) | 36 (88) | |
No therapy | 113 | 18 (16) | 95 (84) | |
Endocrine therapy | 0.336 | |||
Therapy | 47 | 9 (18) | 38 (81) | |
No therapy | 107 | 14 (13) | 93 (87) | |